(AGENPARL) – SILVER SPRING mar 30 maggio 2023 Drug and Biologic Accelerated Approvals Based on a Surrogate Endpoint
Fonte/Source: http://www.fda.gov/drugs/accelerated-approval-program/ongoing-non-malignant-hematology-neurological-disorders-and-other-indications-accelerated-approvals